Price
$43.31
Decreased by -0.51%
Dollar volume (20D)
16.01 M
ADR%
3.87
Earnings report date
Jul 31, 2024
Shares float
48.14 M
Shares short
4.63 M [9.62%]
Shares outstanding
48.60 M
Market cap
2.12 B
Beta
1.75
Price/earnings
4.35 K
20D range
41.76 51.96
50D range
41.76 52.50
200D range
30.18 53.05

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America.

The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns.

The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 29, 24 -0.08
Increased by +50.00%
-0.11
Increased by +27.27%
Feb 29, 24 0.26
Increased by +116.67%
0.17
Increased by +52.94%
Nov 8, 23 -0.08
Increased by +42.86%
-0.12
Increased by +33.33%
Aug 2, 23 -0.11
Increased by +42.11%
-0.15
Increased by +26.67%
May 10, 23 -0.16
Decreased by -6.67%
-0.15
Decreased by -6.67%
Feb 23, 23 0.12
Increased by +33.33%
0.04
Increased by +200.00%
Nov 9, 22 -0.14
Decreased by -27.27%
-0.10
Decreased by -40.00%
Aug 3, 22 -0.19
Decreased by -137.50%
-0.12
Decreased by -58.33%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 51.28 M
Increased by +25.02%
-3.86 M
Increased by +39.06%
Decreased by -7.53%
Increased by +51.25%
Dec 31, 23 65.00 M
Increased by +23.35%
12.99 M
Increased by +119.40%
Increased by +19.99%
Increased by +77.88%
Sep 30, 23 45.58 M
Increased by +18.24%
-3.66 M
Increased by +44.35%
Decreased by -8.03%
Increased by +52.93%
Jun 30, 23 45.92 M
Increased by +23.96%
-5.02 M
Increased by +43.24%
Decreased by -10.93%
Increased by +54.21%
Mar 31, 23 41.02 M
Increased by +13.70%
-6.34 M
Increased by +8.28%
Decreased by -15.45%
Increased by +19.33%
Dec 31, 22 52.69 M
Increased by +10.72%
5.92 M
Increased by +30.61%
Increased by +11.24%
Increased by +17.96%
Sep 30, 22 38.55 M
Increased by +11.72%
-6.58 M
Decreased by -33.38%
Decreased by -17.06%
Decreased by -19.39%
Jun 30, 22 37.05 M
Decreased by -6.26%
-8.84 M
Decreased by -133.60%
Decreased by -23.87%
Decreased by -149.19%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY